Showing results (91-100 of 2,332) with videos related to
Sort By:
Pageof 234
Cancer Treatment Reports|May 1, 1983
Paradoxical behavior of 6-mercaptopurine as a cytotoxic agent: decreasing cell kill with increasing drug doseS Matsumura, T Hoshino, M Weizsaecker, et al.Cancer Treatment Reports|May 1, 1983
Lack of inhibition by oxipurinol of 5-FU toxicity against human tumor cell linesH S Garewal, F R Ahmann, D S AlbertsCancer Treatment Reports|June 1, 1978
Systolic time intervals: an effective measure of cardiac function in anthracycline-induced cardiomyopathy of rabbitsH J LongCancer Treatment Reports|March 1, 1983
Pharmacokinetics of therapeutic doses of isotopically labeled platinum antitumor agents in the mouse and ratA B Robins, M O LeachCancer Treatment Reports|July 1, 1983
Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group StudyF R Ahmann, F L Meyskens, S E Jones, et al.Cancer Treatment Reports|February 1, 1983
Phase I study of tricyclic nucleoside phosphateA Mittelman, E S Casper, T A Godwin, et al.Cancer Treatment Reports|February 1, 1983
Repeated femoral vein cannulation for administration of chemotherapeutic agentsB D Nidus, J L Speyer, J Bottino, et al.Cancer Treatment Reports|May 1, 1984
Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trialS E Krown, M W Burk, J M Kirkwood, et al.Cancer Treatment Reports|May 1, 1984
Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administrationR F Struck, D S AlbertsPageof 234